Literature DB >> 7066174

Unaltered serum propranolol binding by meal-induced variations in fatty acids.

C A Naranjo, E M Sellers, V Khouw.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7066174      PMCID： PMC1402056          DOI： 10.1111/j.1365-2125.1982.tb01425.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  13 in total

1.  Altered drug binding due to the use of indwelling heparinized cannulas (heparin lock) for sampling.

Authors:  M Wood; D G Shand; A J Wood
Journal:  Clin Pharmacol Ther       Date:  1979-01       Impact factor: 6.875

2.  Variable binding of propranolol in human serum.

Authors:  G Sager; O G Nilsen; S Jacobsen
Journal:  Biochem Pharmacol       Date:  1979-03-15       Impact factor: 5.858

3.  The disposition of propranolol. 3. Decreased half-life and volume of distribution as a result of plasma binding in man, monkey, dog and rat.

Authors:  G H Evans; A S Nies; D G Shand
Journal:  J Pharmacol Exp Ther       Date:  1973-07       Impact factor: 4.030

4.  Effect of heparin administration on plasma binding of benzodiazepines.

Authors:  P V Desmond; R K Roberts; A J Wood; G D Dunn; G R Wilkinson; S Schenker
Journal:  Br J Clin Pharmacol       Date:  1980-02       Impact factor: 4.335

5.  Heparin administration increases plasma warfarin binding in man.

Authors:  P A Routledge; T D Bjornsson; B B Kitchell; D G Shand
Journal:  Br J Clin Pharmacol       Date:  1979-09       Impact factor: 4.335

6.  Plasma protein binding of basic drugs. I. Selective displacement from alpha 1-acid glycoprotein by tris(2-butoxyethyl) phosphate.

Authors:  O Borgå; K M Piafsky; O G Nilsen
Journal:  Clin Pharmacol Ther       Date:  1977-11       Impact factor: 6.875

7.  Diurnal fluctuations in triglyceride, free fatty acids, and insulin during sucrose consumption and insulin infusion in man.

Authors:  P J Barter; K F Carroll; P J Nestel
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

8.  Inter- and intrasubject variation in diazepam free fraction.

Authors:  J G Abel; E M Sellers; C A Naranjo; J Shaw; D Kadar; M K Romach
Journal:  Clin Pharmacol Ther       Date:  1979-08       Impact factor: 6.875

9.  Diurnal patterns of triglycerides, free fatty acids, blood sugar, and insulin during carbohydrate-induction in man and their modification by nocturnal suppression of lipolysis.

Authors:  G Schlierf; E Dorow
Journal:  J Clin Invest       Date:  1973-03       Impact factor: 14.808

10.  Effects of caffeine on plasma free fatty acids, urinary catecholamines, and drug binding.

Authors:  R V Patwardhan; P V Desmond; R F Johnson; G D Dunn; D H Robertson; A M Hoyumpa; S Schenker
Journal:  Clin Pharmacol Ther       Date:  1980-09       Impact factor: 6.875
View more
  3 in total

1.  Mechanisms and variations in the food effect on propranolol bioavailability.

Authors:  H Liedholm; E Wåhlin-Boll; A Melander
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 2.  Individual variation in first-pass metabolism.

Authors:  Y K Tam
Journal:  Clin Pharmacokinet       Date:  1993-10       Impact factor: 6.447

3.  PKQuest: a general physiologically based pharmacokinetic model. Introduction and application to propranolol.

Authors:  David G Levitt
Journal:  BMC Clin Pharmacol       Date:  2002-08-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.